charles ryan, md: bone-targeted therapy
Published 8 years ago • 60 plays • Length 1:26
Download video MP4
Download video MP3
Similar videos
-
1:49
dr. ryan on bone-targeting agents for patients with prostate cancer
-
1:43
charles ryan, md: the role of chemotherapy and local therapy
-
4:55
bone targeted therapy for metastatic prostate cancer
-
2:10
charles ryan, md: the differences in side effects between the two ar-targeted therapies
-
0:50
charles ryan, md: comparison of chemotherapy to a secondary hormone at the time of progression
-
2:27
charles ryan, md: follow-up recommendations during and after treatment
-
3:02
charles ryan, md: treatment options and favorable approaches for an elderly patient
-
7:01
safety and efficacy of bone-targeted therapy for mcrpc
-
3:16
a review of bone-targeted therapies
-
1:21
charles ryan, md: biggest concerns and considerations for elderly patient population
-
2:26
charles ryan, md: the efficacy of abiraterone plus prednisone in an elderly patient population
-
1:05:07
january 8, 2019 - charles ryan, md
-
2:09
dr. charles ryan discusses abiraterone and enzalutamide for mcrpc
-
4:18
nonmetastatic crpc: other therapies and coordinating care
-
5:57
managing bone metastasis in patients with mcrpc
-
1:12
dr. charles ryan discusses imaagen trial update for prostate cancer
-
1:16
dr. charles ryan on the cou-aa-302 abiraterone acetate interim analysis results
-
1:35
charles ryan, md: the side effects for prednisone in combination with abiraterone
-
35:08
just diagnosed with kidney cancer--now what? with charles ryan, md and brian rini, md
Clip.africa.com - Privacy-policy